Who invested in Neurophth Therapeutics?
Neurophth Therapeutics's investors include HSG, Northern Light Venture Capital and Oriza Holdings.
Who invested in Neurophth Therapeutics
Funding summaryUpdated 26 Oct 2026
$97Mraised across 1 round since 2023, from 1 source
- Latest round
- Series C, $97MAug 2023
- Investors
- 3
The rounds
- Aug 2023
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Neurophth Therapeutics
How much has Neurophth Therapeutics raised?
Neurophth Therapeutics has raised $97M across 1 round since 2023.
When did Neurophth Therapeutics last raise?
Neurophth Therapeutics's most recent round was a Series C of $97M in Aug 2023.
What was Neurophth Therapeutics's biggest round?
Its most recent round, $97M in Aug 2023, is also its largest on record.
Who backed Neurophth Therapeutics first?
Neurophth Therapeutics's first round on record, in Aug 2023, was backed by HSG, Northern Light Venture Capital and Oriza Holdings.
What stage is Neurophth Therapeutics at?
Neurophth Therapeutics's latest named round is a Series C, in Aug 2023.
Companies like Neurophth Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.